RT Journal Article
SR Electronic
T1 Effects of vaccination against COVID-19 on the emotional health of Peruvian older adults
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.24.22269781
DO 10.1101/2022.01.24.22269781
A1 Alarcon-Ruiz, Christoper A.
A1 Romero-Albino, Zoila
A1 Soto-Becerra, Percy
A1 Huarcaya-Victoria, Jeff
A1 Runzer-Colmenares, Fernando M.
A1 Romani-Huacani, Elisa
A1 Villarreal-Zegarra, David
A1 Maguiña, Jorge L.
A1 Apolaya-Segura, Moises
A1 Cuba-Fuentes, Sofía
YR 2022
UL http://medrxiv.org/content/early/2022/01/25/2022.01.24.22269781.abstract
AB Background COVID-19 vaccination may reduce anxiety and depression. However, the pandemic significantly impacted the elderly from low-middle-income countries. Therefore, we aimed to estimate the effect of vaccination against COVID-19 on the emotional health of older adults.Methods We selected a nationally stratified sample of non-hospitalized adults aged 60 to 79 years who intended to receive the COVID-19 vaccine or had already received it during recruitment. We assess the fear, anxiety, and worry about COVID-19, general anxiety, and depression at baseline and after a month. We estimated the adjusted odds ratios (aOR) and 95% confidence intervals (95% CI) for each altered emotional health outcomes in those who had one and two doses, compared with those who were not vaccinated using multilevel logistic regression with mixed effects.Results We recruited 861 older adults. Loss to follow-up was 20.8%. At baseline, 43.9% had only one dose of the vaccine, and 49.1% had two doses. In the analysis during follow-up, those who had two doses had less fear (ORa: 0.19; CI95%: 0.07 to 0.51) and anxiety to COVID-19 (ORa: 0.45; CI95%: 0.22 to 0.89), compared to non-vaccinated. We observed no effects in those with only one dose.Limitations Inability to obtain the planned sample size for primary analysis. There is a selection bias during recruitment and a measurement bias because of self-reported vaccination.Conclusions COVID-19 vaccination with two doses in elders improves the perception of COVID-19 infection consequences. This information could be integrated into the vaccination campaign as its beneficial effect.HighlightsUp to 90% of elders in a Peruvian sample had at least one dose of COVID-19 vaccineTwo doses of COVID-19 vaccine reduced the levels of fear and anxiety for COVID-19Only one dose of vaccine didn’t had effect in any emotional mental outcomeCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Direccion de Investigacion en Salud, Instituto de Evaluacion de Tecnologias en Salud e Investigacion, IETSI, EsSalud, and the Gerencia de la Persona Adulta Mayor y Prestaciones Sociales, EsSalud. Both funders had no role in the study design, data collection, analysis and interpretation of results, writing of the report, and in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of the Instituto Nacional del Corazon, EsSalud (Certificate of approval 25/2021-CEI) gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors CAMCenters for the elderyCASCoronavirus Anxiety ScaleEsSaludSocial Health Insurance of PeruFCV-19SFear of COVID-19 ScaleGAD-2Generalized Anxiety DisorderPHQ-2Patient Health QuestionnairePRE-COVID-19Scale to measure worry for contagion of the COVID-19